Studies have found that MAD2L1 is overexpressed in lung adenocarcinoma tissues, and the overexpression of MAD2L1 may indicate poor prognosis and increased risk of tumor recurrence in patients, which can be used as a prognostic marker for lung adenocarcinoma [39]. The gene discussed is MAD2L1; the disease is neoplasm.